Search research articles
Contact Us
Filters
Showing results (1-10 of 1,048) with videos related to
Page
of 105
Sort By:
Chest
|
January 9, 2019
Combination of Systemic Inflammatory Response Syndrome and Quick-SOFA: Is This a New Vital Model to Initiate or Escalate Therapy in Patients With Sepsis?
Ran Xu
Computational and Structural Biotechnology Journal
|
July 23, 2020
Statistical methods for the estimation of contagion effects in human disease and health networks
Ran Xu
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine
|
September 18, 2012
[Research and prospect of asymptomatic HIV infection stages]
Li-Ran Xu
Archives of Medical Science : AMS
|
November 22, 2019
Long non-coding RNA FOXF1 adjacent non-coding developmental regulatory RNA inhibits growth and chemotherapy resistance in non-small cell lung cancer
Ran Xu, Yun Han
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 28, 2019
Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma
Yuqiang Mao, Ran Xu
Environmental Toxicology and Pharmacology
|
April 21, 2018
Selection of reference genes for quantitative real-time PCR in Octopus minor (Cephalopoda: Octopoda) under acute ammonia stress
Ran Xu, Xiaodong Zheng
Ecotoxicology (London, England)
|
September 18, 2020
Hemocytes transcriptomes reveal metabolism changes and detoxification mechanisms in response to ammonia stress in Octopus minor
Ran Xu, Xiaodong Zheng
Lung Cancer (Amsterdam, Netherlands)
|
October 8, 2018
Comment on: Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients: Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC
Ran Xu, Jing Zhu
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 28, 2020
CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis
Fushuang Zheng, Ran Xu
Lung Cancer (Amsterdam, Netherlands)
|
September 16, 2018
Comment on: Erlotinib in combination with bevacizumab has potential benefit in non small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials
Ran Xu, Jing Zhu
Page
of 105
Search research articles
Search
Showing results (1-10 of 1,048) with videos related to
Sort By:
Page
of 105
Chest
|
January 9, 2019
Combination of Systemic Inflammatory Response Syndrome and Quick-SOFA: Is This a New Vital Model to Initiate or Escalate Therapy in Patients With Sepsis?
Ran Xu
Computational and Structural Biotechnology Journal
|
July 23, 2020
Statistical methods for the estimation of contagion effects in human disease and health networks
Ran Xu
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine
|
September 18, 2012
[Research and prospect of asymptomatic HIV infection stages]
Li-Ran Xu
Archives of Medical Science : AMS
|
November 22, 2019
Long non-coding RNA FOXF1 adjacent non-coding developmental regulatory RNA inhibits growth and chemotherapy resistance in non-small cell lung cancer
Ran Xu, Yun Han
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 28, 2019
Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma
Yuqiang Mao, Ran Xu
Environmental Toxicology and Pharmacology
|
April 21, 2018
Selection of reference genes for quantitative real-time PCR in Octopus minor (Cephalopoda: Octopoda) under acute ammonia stress
Ran Xu, Xiaodong Zheng
Ecotoxicology (London, England)
|
September 18, 2020
Hemocytes transcriptomes reveal metabolism changes and detoxification mechanisms in response to ammonia stress in Octopus minor
Ran Xu, Xiaodong Zheng
Lung Cancer (Amsterdam, Netherlands)
|
October 8, 2018
Comment on: Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients: Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC
Ran Xu, Jing Zhu
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 28, 2020
CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis
Fushuang Zheng, Ran Xu
Lung Cancer (Amsterdam, Netherlands)
|
September 16, 2018
Comment on: Erlotinib in combination with bevacizumab has potential benefit in non small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials
Ran Xu, Jing Zhu
Page
of 105